Skip to contentR
Rockwell Medical, Inc.
R
RMTIRockwell Medical, Inc. Q3 2022 · 10-Q
Revenue$18.69M$18.69M+16.9% vs Q3 2021 Net Income-$4.19M-$4.19MN/M vs Q3 2021 EPS Diluted-$0.23-$0.23N/M vs Q3 2021 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Rockwell Medical, Inc. · CIK 1041024 · Engraved from SEC EDGAR
Operating Cash Flowderived-$1,102,000N/M Margins · derivedGross margin4.2%+6.2 pt vs Q3 2021
Operating margin-19.8%+23.8 pt vs Q3 2021
Net margin-22.4%+25.0 pt vs Q3 2021
ended Sep 30, 2022 · filed Nov 14, 2022 · 45 d after period end